ARCHIVES

Lung Cancer Clinical Trials Cost-Effective Alternative

This article is from The Cancer Letter archive.

Vol. 26 No. 10 | October 31, 2003

Download PDF Visit The Full Archive

Related Articles

Waxman To Introduce Reauthorization Bill Next Month, Intends To Complete Action By Session End

July 22, 1988

NCI Raises New Questions About Duke Genomics Research, Cuts Assay From Trial

May 14, 2010

Breast Cancer action Plan Calls For More federal Coordination, Patient Participation

March 23, 1994

Intercultural Cancer Council Endorses New NCI Office

July 5, 1996

In Brief: Morgan Named Director Of UAMS Myeloma Institute

April 25, 2014

Adverse Events Of Chemo More Common Than Expected

August 25, 2006